0001140361-14-003404.txt : 20140128
0001140361-14-003404.hdr.sgml : 20140128
20140128124842
ACCESSION NUMBER: 0001140361-14-003404
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140101
FILED AS OF DATE: 20140128
DATE AS OF CHANGE: 20140128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYTRX CORP
CENTRAL INDEX KEY: 0000799698
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 581642750
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11726 SAN VICENTE BOULEVARD
STREET 2: SUITE 650
CITY: LOS ANGELES
STATE: CA
ZIP: 90049
BUSINESS PHONE: 310-826-5648
MAIL ADDRESS:
STREET 1: 11726 SAN VICENTE BOULEVARD
STREET 2: SUITE 650
CITY: LOS ANGELES
STATE: CA
ZIP: 90049
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEVITT DANIEL J
CENTRAL INDEX KEY: 0001278711
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15327
FILM NUMBER: 14551753
MAIL ADDRESS:
STREET 1: C/O DYNAVAX TECHNOLOGIES CORP
STREET 2: 2929 SEVENTH ST STE 100
CITY: BERKELEY
STATE: CA
ZIP: 94710
4/A
1
doc1.xml
FORM 4/A
X0306
4/A
2014-01-01
2014-01-01
0
0000799698
CYTRX CORP
CYTR
0001278711
LEVITT DANIEL J
11726 SAN VICENTE BLVD.
LOS ANGELES
CA
90049
0
1
0
0
EVP and Chief Medical Officer
Common Stock
2014-01-01
4
A
0
100000
0
A
161036
D
A subsequent review by CytRx disclosed that the amount of common stock shares reacquired by the company to satisfy Mr. Levitt's California state tax obligations should be reduced by 3,053, and likewise the amount of shares beneficially owned by him increased by an equivalent amount, from 157,983 as previously reported, to 161,036.
Daniel J. Levitt
2014-01-27